SAN DIEGO -- (BUSINESS WIRE)--Sep. 17, 2026-- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will present at the Stifel 2026 Virtual Immunology and Inflammation ...

This is my thirteenth Ligand article, following my most recent 06/2026's "Ligand Pharma: Expect Bright And Exciting Future ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

We have followed Natera closely over the years, highlighting the stock at different price points - December 21, 2022, when it was trading around $41.75, and August 23, 2024, when it was at $122.82.

In order to achieve this investment objective, the Fund will seek to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the “Index”). It will do so by investing ...